Brief: Clover Biopharmaceuticals Sees Net Profit To Be Not Less Than RMB500 Mln For Six-Month
14/08/2023 07:44
Aug 14 (Reuters) - Clover Biopharmaceuticals Ltd
2197.HK :
* SEES NET PROFIT TO BE NOT LESS THAN RMB500 MILLION FOR
SIX-
MONTH
Further company coverage: 2197.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clover Biopharmaceuticals
See all newsChina's Clover Biopharma H1 revenue drops sharply, flags going-concern doubt
Brief: Clover Biopharmaceuticals Posts FY Loss Of RMB205.1 MLN
Brief: Clover Announces Positive Phase I Clinical Data For Rsv-Hmpv-Piv3 Combination Vaccines And For Rsv Re-Vaccination In Older Adults
Brief: Clover Biopharmaceuticals Posts H1 Revenue Of RMB3.3 Million
Brief: Clover Biopharmaceuticals Says It Terminates Cooperation With Adimmune